Myositis clinical trials at UCLA
3 in progress, 2 open to eligible people
Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
open to eligible people ages 18 years and up
The purpose of the study is to understand how the study medicine PF-06823859 works in people with idiopathic inflammatory myopathies (DM and PM). These disorders cause inflammation that weakens the muscles that are important for movement and may…
Los Angeles, California and other locations
Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.
open to eligible people ages 18 years and up
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy (IIM). Participants with the IIM subtypes of dermatomyositis (DM), immune-mediated…
Los Angeles, California and other locations
Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
Torrance, California and other locations
Our lead scientists for Myositis research studies include Christina Charles-Schoeman, MD.
Last updated: